ANDREW THEUS: Open Payments
NPI 1568029239 · ESTANCIA, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 33 payments from 9 companies in 2025. Trend: 2023 $137 · 2024 $269 · 2025 $1,291
Food & beverage: $1,291
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $288 |
| ABBVIE INC. | 11 | $264 |
| Janssen Biotech, Inc. | 8 | $248 |
| Gilead Sciences, Inc. | 3 | $149 |
| Regeneron Healthcare Solutions, Inc. | 2 | $147 |
| Phathom Pharmaceuticals, Inc. | 1 | $119 |
| Exact Sciences Corporation | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: REZDIFFRA, TREMFYA, DUPIXENT, SKYRIZI, Livdelzi, VOQUEZNA, RINVOQ, LINZESS.
Industry payments across NM — which companies pay providers there.
